search for
Search
Search
About
Help
Web Service
Extended-release opioid agonists and antagonist medications for addiction treatment (MAT) in patients with opioid use disorder: effectiveness and value : final evidence report
Collection:
Health Policy and Services Research
Contributor(s):
Institute for Clinical and Economic Review, issuing body. New England Comparative Effectiveness Public Advisory Council, issuing body.
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, December 3, 2018
Language(s):
English
Format:
Text
Subject(s):
Analgesics, Opioid -- therapeutic use
Narcotic Antagonists -- therapeutic use
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Buprenorphine -- therapeutic use
Buprenorphine, Naloxone Drug Combination -- therapeutic use
Cost-Benefit Analysis
Methadone -- therapeutic use
Naltrexone -- therapeutic use
Treatment Outcome
Humans
United States
Genre(s):
Technical Report
Copyright:
Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY license.
(More information)
Extent:
1 online resource (1 PDF file (1 v. (various pagings)))
Illustrations:
Illustrations
NLM Unique ID:
101745061 (
See catalog record
)
Permanent Link:
http://resource.nlm.nih.gov/101745061
Download
PDF
Plain Text
Metadata (Dublin Core)